News | April 15, 2023
Taros Chemicals and Welab Barcelona partner for drug Discovery and development services
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The combination will support clients in getting their end-to-end discovery and development programs delivered.
NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
To enable company to be future-ready by tapping potential in CDMO space
Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Proposed combination enhances Pfizer’s position as a leading company in oncology
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Subscribe To Our Newsletter & Stay Updated
